PensionDanmark Pensionsforsikringsaktieselskab Purchases 11,455 Shares of Cardinal Health, Inc. $CAH

PensionDanmark Pensionsforsikringsaktieselskab grew its holdings in shares of Cardinal Health, Inc. (NYSE:CAH) by 15.1% during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 87,295 shares of the company’s stock after purchasing an additional 11,455 shares during the period. PensionDanmark Pensionsforsikringsaktieselskab’s holdings in Cardinal Health were worth $20,738,000 at the end of the most recent quarter.

A number of other hedge funds also recently modified their holdings of the stock. University of Texas Texas AM Investment Management Co. bought a new position in Cardinal Health in the 4th quarter valued at about $26,000. Jones Financial Companies Lllp grew its position in Cardinal Health by 198.3% in the first quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock valued at $27,000 after acquiring an additional 14,034 shares during the last quarter. Bank of Jackson Hole Trust acquired a new position in Cardinal Health during the fourth quarter worth about $27,000. Palladiem LLC bought a new position in shares of Cardinal Health in the fourth quarter worth about $28,000. Finally, Indiana Trust & Investment Management Co bought a new stake in shares of Cardinal Health during the 1st quarter valued at approximately $29,000. Institutional investors own 87.17% of the company’s stock.

Cardinal Health Stock Performance

Shares of NYSE CAH opened at $237.66 on Friday. Cardinal Health, Inc. has a 52-week low of $137.75 and a 52-week high of $244.87. The company’s 50 day moving average price is $225.84 and its 200-day moving average price is $216.08. The company has a market capitalization of $55.66 billion, a P/E ratio of 36.34, a price-to-earnings-growth ratio of 1.17 and a beta of 0.49.

Wall Street Analyst Weigh In

CAH has been the topic of a number of research analyst reports. JPMorgan Chase & Co. cut their target price on shares of Cardinal Health from $243.00 to $215.00 and set a “neutral” rating on the stock in a research report on Monday, May 4th. William Blair started coverage on Cardinal Health in a research report on Tuesday, April 28th. They set an “outperform” rating on the stock. Robert W. Baird set a $248.00 target price on Cardinal Health in a report on Friday, May 1st. TD Cowen boosted their price target on Cardinal Health from $255.00 to $275.00 and gave the stock a “buy” rating in a report on Thursday, July 9th. Finally, Morgan Stanley raised their price objective on shares of Cardinal Health from $245.00 to $255.00 and gave the company an “overweight” rating in a report on Tuesday, April 28th. Fifteen analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $251.73.

About Cardinal Health

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.